Aviva’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.52M | Buy |
33,122
+31,270
| +1,688% | +$8.99M | 0.02% | 527 |
|
|
2025
Q1 | $571K | Buy |
1,852
+194
| +12% | +$59.8K | ﹤0.01% | 759 |
|
|
2024
Q4 | $585K | Sell |
1,658
-6,623
| -80% | -$2.34M | ﹤0.01% | 726 |
|
|
2024
Q3 | $2.97M | Sell |
8,281
-206
| -2% | -$73.8K | 0.01% | 519 |
|
|
2024
Q2 | $2.7M | Buy |
8,487
+5,843
| +221% | +$1.86M | 0.01% | 556 |
|
|
2024
Q1 | $607K | Buy |
2,644
+63
| +2% | +$14.5K | ﹤0.01% | 840 |
|
|
2023
Q4 | $568K | Sell |
2,581
-18,044
| -87% | -$3.97M | ﹤0.01% | 861 |
|
|
2023
Q3 | $4.66M | Buy |
+20,625
| New | +$4.66M | 0.02% | 519 |
|
|
2023
Q2 | – | Sell |
-91,015
| Closed | -$20.4M | – | 1023 |
|
|
2023
Q1 | $20.4M | Buy |
91,015
+79,312
| +678% | +$17.8M | 0.09% | 331 |
|
|
2022
Q4 | $3.25M | Sell |
11,703
-3,191
| -21% | -$887K | 0.02% | 641 |
|
|
2022
Q3 | $3.12M | Sell |
14,894
-2,131
| -13% | -$446K | 0.02% | 640 |
|
|
2022
Q2 | $4.01M | Buy |
+17,025
| New | +$4.01M | 0.02% | 627 |
|
|
2021
Q2 | – | Sell |
-7,249
| Closed | -$1.21M | – | 978 |
|
|
2021
Q1 | $1.21M | Sell |
7,249
-5,064
| -41% | -$847K | 0.01% | 830 |
|
|
2020
Q4 | $1.87M | Sell |
12,313
-9,981
| -45% | -$1.52M | 0.01% | 685 |
|
|
2020
Q3 | $2.25M | Buy |
22,294
+3,254
| +17% | +$329K | 0.01% | 724 |
|
|
2020
Q2 | $2.3M | Buy |
+19,040
| New | +$2.3M | 0.01% | 686 |
|